EP2233149
Combination of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) and anti-CD20 agents for treatment of autoimmune disease
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.10.2008EP published:
10.2.2016EP application number:
10167232.7
EPO information:
European Patent Register
Max expiry date:
15.10.2028
Title:
Combination of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) and anti-CD20 agents for treatment of autoimmune disease
Timeline
Today
16.10.2008EP application
10.2.2016EP Publication
Owner
Name:
ZymoGenetics, Inc.Address:
1201 Eastlake Avenue East, 98102, Seattle, Washington, US
Name:
ARES TRADING S.A.Address:
Zone Industrielle de l'Ouriettaz, 1170, Aubonne, CH
Inventor
Name:
Broly, HerveAddress:
Saint Selve, FR
Name:
Ponce Jr., Rafael A.Address:
Seattle, WA, US
Name:
Graffner, Hans Otto LennartAddress:
252 84 Helsingborg, SE
Name:
Peano, SergioAddress:
Ivrea (to), IT
Priority
Number:
980331 PDate:
16.10.2007Country:
US
Classification
Categories:
A61K 38/17, A61K 39/395, C07K 19/00, C07K 16/28, A61P 37/00